Please login to the form below

Understanding personas for healthcare

In this article, Head of Insight Martine Leroy tackles the persona. Here, she breaks down for us what a persona is in the context of customer-centric design, and addresses some frequently asked questions about these and other tools used for improving customer engagement.
In recent years, there has been a big shift in how pharma and healthcare companies approach the design and development of patient services. Something we’ve talked about a lot at Blue Latitude Health is the move toward customer-centricity and what that actually means in the healthcare and pharma context. Out of those conversations has emerged a need for more clarity around some of the tools used in the customer-centric design process.

In this article, Head of Insight Martine Leroy tackles one of those tools: the persona. Here, she breaks down for us what a persona is in the context of customer-centric design, and addresses some frequently asked questions about these and other tools used for improving customer engagement.
 


What is a persona, and how does it differ from a pen portrait or a segment?

First, let’s remember that personas, pen portraits and segments are all tools designed for a specific objective and that they need to be fit for that purpose. Additionally, the three tools are developed from the bottom up, which means they are grounded in customer-centric data and information.  

Simply put, a persona is an individual representation of a group of customers and their behaviours, attitudes, and context. It’s a tool that gives life to the customer by illustrating their everyday activities, frustrations, pain points, and motivations. Driven by quantitative and qualitative data about actual customers, the persona is a valuable tool and point of reference used to keep the customer at the centre of the design process.


Pen portraits and customer segments are also tools that are used in the design process to improve customer engagement, but they are generated differently from a persona. A pen portrait is one level above the persona – it is broader, and is considered an overview of who the customer might be and what they might do. The pen portrait focuses on general customer lifestyle or on their role, related needs, and actions.


A customer segment is designed to support targeted communications and marketing. We do customer segmentation to identify and summarise groups of potential (or existing) customers, focusing on what drives their behaviour. In pharma, we tend to develop physician segments based on their attitudes and prescribing behaviours, and also increasingly develop segments for other healthcare professionals (HCPs). In each of those segments might exist 2-3 different personas, HCPs who exhibit similar prescribing behaviour but who are driven by different motivations.



Download the full article from Blue Latitude Health

29th April 2016

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

In the precision medicine era, the line between products and services is blurred
Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?
Blue Latitude Health
Understanding COVID-19 and varying responses across the globe
At the beginning of the COVID-19 Pandemic, Senior Account Executive Lauren Fernandes took a course at the London School of Hygiene and Tropical Medicine to better understand how the global response to the virus and to ensure we were best positioned to serve our clients during this challenging time. She shares the key learnings and why understanding the epidemiology of the disease is integral for fighting it.
Blue Latitude Health
Top 5 tips for a multi-indication product launch
Senior Associate Consultant Sana Rahim and Senior Consultant Victoria Clark explain the lessons the team has learned from launching six different indications of an oncology product in an accelerated timeframe.
Blue Latitude Health
If our patients are diverse, why are clinical trials so white?
Despite facing worse health outcomes, minority populations are often left out of clinical trials and miss the opportunity to participate in life-saving research. Associate Consultant Ling Song explores this issue and calls for the pharmaceutical industry to change its approach.
Blue Latitude Health
Engaging physicians during COVID-19
COVID-19 has drastically changed the lives of healthcare professionals. They are emotionally and physically drained and under huge amounts of pressure. They also need pharma’s help. Senior Consultant Pany Koizi outlines five principles for engaging with physicians during the pandemic.
Blue Latitude Health
Fishawack Health adds market access and commercial strategy consultancy Skysis as part of its bold growth plans
Fishawack Health, the global healthcare communications agency, announces the acquisition of Skysis, a boutique consulting firm providing integrated market access and commercial strategy solutions based in the US.
Blue Latitude Health